Stockscreener 앱 받기
7.02
0.71%
-0.05
시장 영업 전:
7.14
0.12
+1.71%
전일 마감가:
$7.07
열려 있는:
$6.78
하루 거래량:
559.67K
Relative Volume:
1.71
시가총액:
$598.55M
수익:
-
순이익/손실:
$-29.64M
주가수익비율:
-16.33
EPS:
-0.43
순현금흐름:
$-39.43M
1주 성능:
-16.63%
1개월 성능:
-7.63%
6개월 성능:
+101.15%
1년 성능:
+145.45%
1일 변동 폭
$6.30
$7.05
1주일 범위
$6.30
$8.40
52주 변동 폭
$2.30
$8.60
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
7.02 | 602.82M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-15 | 개시 | Citigroup | Buy |
| 2023-04-24 | 개시 | H.C. Wainwright | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 개시 | Piper Sandler | Overweight |
| 2022-04-04 | 개시 | Citigroup | Buy |
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
Alpha Tau Medical Shares Fall After Piper Sandler Downgrade - marketscreener.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com South Africa
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Piper Sandler Reiterates Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
DRTS Receives Downgrade from Piper Sandler with Neutral Rating | - GuruFocus
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Canada
Alpha Tau Medical (DRTS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Is Alpha Tau Medical Ltd. Equity Warrant benefiting from interest rate changes2025 Key Lessons & Long-Term Growth Portfolio Plans - mfd.ru
DRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 6.89% Upside in Innovative Cancer Treatment Technology - DirectorsTalk Interviews
Alpha Tau Medical (DRTSW) to Release Earnings on Thursday - Defense World
DRTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighWhat's Next? - MarketBeat
H.C. Wainwright raises Alpha Tau Medical price target on Japan approval - Investing.com Nigeria
Shorts Report: Will Alpha Tau Medical Ltd benefit from rate cutsJuly 2025 Rallies & Daily Momentum Trading Reports - baoquankhu1.vn
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright - Yahoo Finance
Alpha Tau Lands First International Approval as Japan Grants Mar - GuruFocus
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS) - TipRanks
H.C. Wainwright Maintained Buy on Alpha Tau Medical Ltd. (DRTS) Feb 2026 - Meyka
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT - Business Wire
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy - TipRanks
Alpha Tau Medical receives Japanese marketing approval for Alpha Dart in head and neck cancer - marketscreener.com
Japan grants Shonin approval for Alpha Tau (DRTS) Alpha DaRT cancer therapy - Stock Titan
Alpha Tau Medical Receives Japanese Marketing Approval for - GlobeNewswire
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga España
CEO Change: Will MPLX benefit from seasonalityPortfolio Gains Summary & Consistent Growth Equity Picks - baoquankhu1.vn
Risk Off: What is FORLUs valuation compared to sectorPortfolio Value Summary & Risk Controlled Stock Alerts - baoquankhu1.vn
Retail Trends: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demand2025 Price Momentum & Fast Gain Stock Tips - baoquankhu1.vn
Macro Review: Will Plumas Bancorp benefit from rising consumer demandJuly 2025 Outlook & Reliable Price Action Trade Plans - baoquankhu1.vn
Aug PreEarnings: Can Alpha Tau Medical Ltd sustain its profitabilityJuly 2025 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Lucid Diagnostics (NASDAQ:LUCD) & Alpha Tau Medical (NASDAQ:DRTS) Financial Survey - Defense World
Support Test: Should I invest in Alpha Tau Medical Ltd. before earningsPortfolio Performance Report & Fast Gain Stock Trading Tips - mfd.ru
Alpha Tau Medical (NASDAQ:DRTS) Upgraded at Zacks Research - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 2.2% – Should You Sell? - Defense World
VIX Spike: Is Alpha Tau Medical Ltd Equity Warrant in a bullish channelInsider Buying & Accurate Buy Signal Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd. Equity Warrant stock overvalued or fairly priced2025 Market Overview & Safe Capital Preservation Plans - mfd.ru
Is Alpha Tau Medical Ltd. Equity Warrant stock a good pick for beginners2025 Stock Rankings & Real-Time Market Sentiment Reports - mfd.ru
What hedge fund activity signals for Alpha Tau Medical Ltd. stock2025 Short Interest & Accurate Entry and Exit Point Alerts - mfd.ru
Big Picture: What is the Moat Score of Alpha Tau Medical Ltd.Trade Risk Report & Free Risk Controlled Daily Trade Plans - mfd.ru
Can Alpha Tau Medical Ltd. Equity Warrant reach all time highs this yearDip Buying & AI Powered Buy/Sell Recommendations - mfd.ru
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Unveiling a 10.74% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
Should you buy the dip on Alpha Tau Medical Ltd. Equity WarrantPortfolio Profit Report & Consistent Profit Alerts - mfd.ru
What’s next for Alpha Tau Medical Ltd. stockQuarterly Earnings Report & Consistent Income Trade Recommendations - mfd.ru
Alpha Tau Medical (NASDAQ:DRTS) Shares Down 6.6%Here's What Happened - MarketBeat
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛
Energy Moves: How does Alpha Tau Medical Ltd compare to its peersOptions Play & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
IPO Launch: Is Alpha Tau Medical Ltd stock showing strong momentumQuarterly Profit Review & Capital Protection Trading Alerts - baoquankhu1.vn
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short Interest - Defense World
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 111.0% - MarketBeat
DRTSWAlpha Tau Medical Ltd Latest Stock News & Market Updates - Stock Titan
Alpha Tau Medical Ltd (DRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
6.00%
자본화:
|
볼륨(24시간):